AUM Cardiovascular is a Minnesota company that helps doctors better diagnose and treat blockages in the heart with a device called the CADence System. The founder of the company, Dr. Marie Johnson, developed algorithms and signal processing techniques used to detect and analyze heart disease after losing her husband to a heart attack in 2002. AUM Cardiovascular and its talented team turned what was a tragedy into 2011’s top innovation, the CADence system.
The CADence system is a non-invasive, hand-held device capable of detecting coronary artery disease in roughly 20 seconds. Compared to other tests, the CADence system is much faster, does not require a dedicated space or specialized staff, has very little cost for each patient, and also does not require pharmaceutical dye. These revolutionary features make the CADence test more practical and readily available.
Dr. Johnson is currently conducting a clinical study with cardiologist Dr. Robert Wilson, MD, at the University of Minnesota, which is set conclude in May. AUM Cardiovascular has raised $98,000 in IRS grant funding, $50,000 in Minnesota Cup prize money, and $1.3 million from Minnesota-based angel investors to fund the production of its groundbreaking device.
AUM Cardiovascular will be presenting at the Innovation Hall of the Governor’s Job Summit at the St. Paul Crown Plaza on October 25. The company’s dedication to medical advancements are important to the state as we get Minnesota working again.